New hope for tough cancers: first test of experimental drug ZM008 begins
Disease control
Recruiting now
This early-stage trial is testing a new experimental drug called ZM008 in adults with advanced solid tumors who have run out of standard treatment options. The study will first determine safe doses of ZM008 given alone, then test it in combination with an existing immunotherapy d…
Phase: PHASE1 • Sponsor: Zumutor Biologics Inc. • Aim: Disease control
Last updated Apr 04, 2026 07:51 UTC